How Lawmakers and Candidates
Can Earn LongeviPAC Support!

This is a living document of our priorities and supported initiatives. Have suggestions about other longevity policies we should consider? Email us at admin@longevipac.org

America can transform the current “sickcare” system into true healthcare, expanding the lives and health of all individuals by decades, vanquishing ailments that have plagued humanity since the beginning, and even slowing aging itself. But substantial public policy reforms are crucial for unleashing the researchers, innovators, and entrepreneurs who are creating and using exponential technology to launch our longevity revolution. Japan has an average life expectancy of 85 years old; for America, it’s only 75. Our country can do much better. You can earn LongeviPAC backing through the following efforts.

1. Funding priorities: Support and target funding for foundational anti-aging research and development of treatments for aging to federal entities such as the National Institute of Aging – Division of Aging Biology, and the Advanced Research Projects Agency for Health and associated entities.
2. FDA biomarkers for anti-aging therapies: Support legislation requiring the Food and Drug Administration to define biomarkers and endpoints for clinical trials or AI testing that will allow evaluation of anti-aging therapeutics, with outreach to and partnership with private researchers and enterprises. 
3. Patient access to therapies: Support legislation, like the Alliance for Longevity Initiatives AAPLM policy proposal to establish a dedicated FDA regulatory pathway prioritizing approval of longevity treatments; the Promising Pathway Act, to create quicker and wider access for patients to safe and promising treatments still in FDA testing; and legislation at the state or federal level to significantly expand “Right To Try.”
4. Documenting economic benefits: Support funding for Congressional-backed research, through agencies like the Center for Scientific Review, National Institutes of Health, and Congressional Budget Office, documenting the economic benefits of introducing effective anti-aging therapeutics.
5. Insurance incentives for personal health: Support proposals, including tax relief, at the state or federal level, to allow insurance rates that reward efforts by individuals—e.g., diet, exercise, health monitoring—to prevent chronic, age-related diseases.
6. Longevity education: Promote through legislative communications channels to other lawmakers and policymakers regular information about the benefits of promising anti-aging efforts; share such information through social media, especially highlighting the importance of longevity science and anti-aging breakthroughs, especially in light of the impending “silver tsunami” demographic crisis of an aging population.
7. Participation in longevity communities: Engage with longevity communities of scientists, researchers, entrepreneurs, industry leaders, patient groups, and advocates by attending conferences, visiting research institutions, and participating in public forums, both to lend your support for these efforts and to keep yourself up-to-date on advances that can increase healthspan and lifespan.
8. Expand international cooperation: Create with other countries arrangements modeled on the Britain-Israel Research and Academic Exchange Partnership on Aging.
9. Join the Longevity Science Caucus: Use this vehicle in the U.S. House and Senate to support the above efforts.